Subscribe to Email Alerts
Menu
About Us
Company
Cancer Diagnostics Market
Board
Executive
Advisors
Partners
Distributors
Careers
Technology
Our Technologies
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
hTERT ICC Test
EXO-NET® (RUO)
FAQ
Pipeline
Diagnostics Pipeline
Investors
Snapshot
ASX Announcements
Reports
Presentations
Share Price Information
Analyst Coverage
Corporate Governance
Finance News Network Videos
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Snapshot
ASX Announcements
Reports
Presentations
Share Price Information
Analyst Coverage
Corporate Governance
Finance News Network Videos
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
6-Apr-2022
Updated Investor Presentation
6-Apr-2022
SubB2M Paper Published in BMC Cancer Journal
5-Apr-2022
INOVIQ Engages ResearchDX to Develop & Validate SubB2M-Tests
1-Apr-2022
INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test
28-Mar-2022
Update on Legal Proceedings and BARD1 Autoantibody Program
25-Feb-2022
Appendix 4D and Half Year Financial Report
23-Feb-2022
Brazilian Patent Issued for Lung & Colorectal Cancer
31-Jan-2022
Notification regarding unquoted securities - IIQ
31-Jan-2022
Appendix 4C & Quarterly Activities Report
17-Jan-2022
US Patent Issued - BARD1 Breast & Ovarian Cancer Diagnosis
Previous
1
2
3
Next
